William Blair analyst Myles Minter reiterated an Outperform rating on Larimar Therapeutics (NASDAQ: LRMR)The analyst commented, "Larimar continues to work ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments